GALECTIN THERAPEUTICS INC — Director's Dealing 2017

Dec 18, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2017-12-14

Reporting Person: Uihlein Richard E (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-14	Common Stock	A	14644	$2.39	Acquired	2524553	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-14	Stock option (right to buy)	$2.39	A	46875	Acquired	2027-12-14	Common stock (46875)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20000	Indirect

Footnotes

F1: These restricted shares were issued in lieu of cash retainer and meeting fees of $35,000 for 2018. Restrictions on the shares lapse at a rate of 25% per calendar quarter in 2018.

F2: The reporting person is president and director of Ed Uihein Family Foundation, a not-for-profit corporation. The reportion person has no pecuniary interest in the shares, however, he shares voting and dispositive power over the shares and, therefore, remains the beneficial owner of the shares solely for purposes of Section 13(d) of the Securities Exchange Act of 1934.

F3: The options vest 100% on December 14, 2018.